sphingosine-1-phosphate

You have access
Anticancer Effects of BAF312 (Siponimod) in Epithelial Ovarian Cancer
HEEEUN HA, JI-YOON RYU, SUIN YOON, YOUNG-JAE CHO, JUNG-JOO CHOI, JAE RYOUNG HWANG, JU-YEON CHOI, HEE DONG HAN and JEONG-WON LEE

Anticancer Research October 2024, 44 (10) 4273-4282; DOI: https://doi.org/10.21873/anticanres.17257
You have access
Clinical Significance of Phosphorylated Sphingosine Kinase 1 Expression in Pancreatic Ductal Adenocarcinoma
HIROKI NAGARO, HIROSHI ICHIKAWA, KAZUYASU TAKIZAWA, MASAYUKI NAGAHASHI, SHUN ABE, YUKI HIROSE, KAZUKI MORO, KOHEI MIURA, MASATO NAKANO, YOSHIFUMI SHIMADA, JUN SAKATA and TOSHIFUMI WAKAI

Anticancer Research September 2023, 43 (9) 3969-3977; DOI: https://doi.org/10.21873/anticanres.16584
You have access
Bioactive Sphingolipids as Biomarkers Predictive of Disease Severity and Treatment Response in Cancer: Current Status and Translational Challenges
MIRELA SEDIĆ, PETRA GRBČIĆ and SANDRA KRALJEVIĆ PAVELIĆ

Anticancer Research January 2019, 39 (1) 41-56; DOI: https://doi.org/10.21873/anticanres.13078
You have access
Targeting Ovarian Cancer and Chemoresistance Through Selective Inhibition of Sphingosine Kinase-2 with ABC294640
MARTIN D. WHITE, LUCAS CHAN, JAMES W. ANTOON and BARBARA S. BECKMAN

Anticancer Research September 2013, 33 (9) 3573-3579;

Main menu